Rein Therapeutics, Inc. (RNTX)
Nasdaq: RNTX · CIK 0001420565 · United States
Every official Rein Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RNTX filings
Rein Therapeutics, Inc. documents
- Rein Therapeutics, Inc. 10-K 2026RNTX 10-K 2026: annual report for fiscal 2026
- Rein Therapeutics, Inc. 10-K 2025RNTX 10-K 2025: annual report for fiscal 2025
- Rein Therapeutics, Inc. 10-K 2024RNTX 10-K 2024: annual report for fiscal 2024
- Rein Therapeutics, Inc. 10-K 2023RNTX 10-K 2023: annual report for fiscal 2023
- Rein Therapeutics, Inc. 10-K 2022RNTX 10-K 2022: annual report for fiscal 2022
- Rein Therapeutics, Inc. 10-Q 2026RNTX 10-Q 2026: quarterly report for fiscal 2026
- Rein Therapeutics, Inc. 10-Q 2025RNTX 10-Q 2025: quarterly report for fiscal 2025
- Rein Therapeutics, Inc. 10-Q 2024RNTX 10-Q 2024: quarterly report for fiscal 2024
- Rein Therapeutics, Inc. 10-Q 2023RNTX 10-Q 2023: quarterly report for fiscal 2023
- Rein Therapeutics, Inc. 10-Q 2022RNTX 10-Q 2022: quarterly report for fiscal 2022
- Rein Therapeutics, Inc. 8-K 2026RNTX 8-K 2026: current report for fiscal 2026
- Rein Therapeutics, Inc. 8-K 2025RNTX 8-K 2025: current report for fiscal 2025
- Rein Therapeutics, Inc. 8-K 2024RNTX 8-K 2024: current report for fiscal 2024
- Rein Therapeutics, Inc. 8-K 2023RNTX 8-K 2023: current report for fiscal 2023
- Rein Therapeutics, Inc. 8-K 2022RNTX 8-K 2022: current report for fiscal 2022
- Rein Therapeutics, Inc. DEF 14A 2026RNTX DEF 14A 2026: proxy statement for fiscal 2026
- Rein Therapeutics, Inc. DEF 14A 2025RNTX DEF 14A 2025: proxy statement for fiscal 2025
- Rein Therapeutics, Inc. DEF 14A 2024RNTX DEF 14A 2024: proxy statement for fiscal 2024
- Rein Therapeutics, Inc. DEF 14A 2023RNTX DEF 14A 2023: proxy statement for fiscal 2023
- Rein Therapeutics, Inc. DEF 14A 2022RNTX DEF 14A 2022: proxy statement for fiscal 2022
- Rein Therapeutics, Inc. Form 4 2026RNTX Form 4 2026: insider trading filing for fiscal 2026
- Rein Therapeutics, Inc. Form 4 2025RNTX Form 4 2025: insider trading filing for fiscal 2025
- Rein Therapeutics, Inc. Form 4 2024RNTX Form 4 2024: insider trading filing for fiscal 2024
- Rein Therapeutics, Inc. Form 4 2023RNTX Form 4 2023: insider trading filing for fiscal 2023
- Rein Therapeutics, Inc. Form 4 2022RNTX Form 4 2022: insider trading filing for fiscal 2022
- Rein Therapeutics, Inc. S-1 2026RNTX S-1 2026: registration statement for fiscal 2026
- Rein Therapeutics, Inc. S-1 2025RNTX S-1 2025: registration statement for fiscal 2025
- Rein Therapeutics, Inc. S-1 2024RNTX S-1 2024: registration statement for fiscal 2024
- Rein Therapeutics, Inc. S-1 2023RNTX S-1 2023: registration statement for fiscal 2023
- Rein Therapeutics, Inc. S-1 2022RNTX S-1 2022: registration statement for fiscal 2022
- Rein Therapeutics, Inc. 13F 2026RNTX 13F 2026: institutional holdings for fiscal 2026
- Rein Therapeutics, Inc. 13F 2025RNTX 13F 2025: institutional holdings for fiscal 2025
- Rein Therapeutics, Inc. 13F 2024RNTX 13F 2024: institutional holdings for fiscal 2024
- Rein Therapeutics, Inc. 13F 2023RNTX 13F 2023: institutional holdings for fiscal 2023
- Rein Therapeutics, Inc. 13F 2022RNTX 13F 2022: institutional holdings for fiscal 2022
More companies